GlassScriptPhysician profile
Medhat M Osman
NPI 1932117819
$347,214.91
in general payments reported to CMS, 2019-2025
12 companies · $71K in 2025
The $71K reported for 2025 was more than what 99% of Nuclear Medicine providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,250 · 2022: $41K · 2023: $123K · 2024: $109K · 2025: $71K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $248K · Travel and Lodging: $44K · Food and Beverage: $5,765 · Consulting Fee: $3,713 · Honoraria: $1,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $247,851.25 |
| Travel and Lodging | $43,732.51 |
| Food and Beverage | $5,764.68 |
| Consulting Fee | $3,712.50 |
| Honoraria | $1,700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $322,009.72 | 2022-2025 | Pylarify |
| Lantheus Medical Imaging, INC. | $11,092.04 | 2024 | |
| Novartis Pharmaceuticals Corporation | $5,504.89 | 2022-2025 | |
| Blue Earth Diagnostics | $3,400.00 | 2022-2023 | |
| Advanced Accelerator Applications | $3,250.11 | 2019 | |
| Telix Pharmaceuticals | $1,870.21 | 2025 | |
| Curium US LLC | $50.83 | 2022 | |
| Ge Healthcare | $23.29 | 2022 | |
| Abiomed | $13.82 | 2025 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Medhat Osman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.